AU3282597A - New fibrinogen binding protein originating from coagulase-negative staphylococcus - Google Patents

New fibrinogen binding protein originating from coagulase-negative staphylococcus

Info

Publication number
AU3282597A
AU3282597A AU32825/97A AU3282597A AU3282597A AU 3282597 A AU3282597 A AU 3282597A AU 32825/97 A AU32825/97 A AU 32825/97A AU 3282597 A AU3282597 A AU 3282597A AU 3282597 A AU3282597 A AU 3282597A
Authority
AU
Australia
Prior art keywords
protein
fibrinogen binding
coagulase
binding protein
negative staphylococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32825/97A
Other languages
English (en)
Inventor
Jan-Ingmar Flock
Lars Frykberg
Bengt Guss
Martin Lindberg
Martin Nilsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nilson Martin
Original Assignee
Nilson Martin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nilson Martin filed Critical Nilson Martin
Publication of AU3282597A publication Critical patent/AU3282597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU32825/97A 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus Abandoned AU3282597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9602496 1996-06-20
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology
PCT/SE1997/001091 WO1997048727A1 (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus

Publications (1)

Publication Number Publication Date
AU3282597A true AU3282597A (en) 1998-01-07

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32825/97A Abandoned AU3282597A (en) 1996-06-20 1997-06-18 New fibrinogen binding protein originating from coagulase-negative staphylococcus

Country Status (10)

Country Link
US (2) US6733758B1 (enExample)
EP (1) EP0922056B1 (enExample)
JP (1) JP4173549B2 (enExample)
AT (1) ATE316979T1 (enExample)
AU (1) AU3282597A (enExample)
CA (1) CA2294433A1 (enExample)
DE (1) DE69735207T2 (enExample)
ES (1) ES2258280T3 (enExample)
SE (1) SE9602496D0 (enExample)
WO (1) WO1997048727A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
AU1537699A (en) * 1997-11-26 1999-06-15 Bioresearch Ireland a division of Eolas - The Irish Science and Technology Agency Extracellular matrix-binding proteins from (staphylococcus aureus)
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6635473B1 (en) * 1998-08-31 2003-10-21 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Polypeptides and polynucleotides from coagulase-negative staphylococci
CA2341177A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
EP2320233A1 (en) 2001-06-15 2011-05-11 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
CA2478029A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
ES2730275T3 (es) 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
KR101541383B1 (ko) 2006-03-30 2015-08-03 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2007127339A2 (en) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Multi-stage microporation device
SI2445522T1 (sl) 2009-06-22 2017-10-30 Wyeth Llc Imunogeni sestavki antigenov Staphylococcusa aureusa
CA2768204A1 (en) 2009-07-15 2011-01-20 Aimm Therapeutics B.V. Gram-positive bacteria specific binding compounds
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
KR20230031322A (ko) 2020-06-27 2023-03-07 크레센타 바이오사이언시즈 세포 물질대사를 조정하는 화합물의 조성물 및 사용 방법
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ATE95187T1 (de) * 1988-07-15 1993-10-15 Thomae Gmbh Dr K Verfahren zur gewinnung, isolierung und reinigung von epidermin.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
EP0621875B1 (en) * 1992-09-21 2002-03-27 Alfa-Laval Agri International Ab Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
ATE316979T1 (de) 2006-02-15
CA2294433A1 (en) 1997-12-24
SE9602496D0 (sv) 1996-06-20
JP2001503609A (ja) 2001-03-21
DE69735207T2 (de) 2006-11-02
JP4173549B2 (ja) 2008-10-29
US20040209326A1 (en) 2004-10-21
WO1997048727A1 (en) 1997-12-24
EP0922056B1 (en) 2006-02-01
US7160990B2 (en) 2007-01-09
US6733758B1 (en) 2004-05-11
ES2258280T3 (es) 2006-08-16
EP0922056A1 (en) 1999-06-16
DE69735207D1 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
AU3282597A (en) New fibrinogen binding protein originating from coagulase-negative staphylococcus
AU2001294541A1 (en) Mammalian genes; related reagents and methods
WO1995018830A3 (en) Inhibitors of human plasmin derived from the kunitz domains
NZ502391A (en) Mammalian cytokine: interleukin-B30 and related reagents
DE69131580D1 (de) GDF-1 und UOG1 Proteine
NZ270659A (en) Mammalian protein which binds to a gst-fkbp-rapamycin complex, dna therefor and diagnostic compositions
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
EP0832975A3 (en) Histidinol dehydrogenase from Staphylococcus aureus
ATE125867T1 (de) Fibronektinbindungsprotein und dessen herstellung.
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DE69933998D1 (de) Verbindungen und verfahren für therapie und diagnose von lungenkrebs
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
MXPA02008239A (es) Gen humano de la esquizofrenia.
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
AU7017494A (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
EP0990703A4 (en) NEW POLYPEPTIDE, FOR CODING DNA AND THEIR USE
AU5305300A (en) Mammalian receptor proteins; related reagents and methods
IL130164A0 (en) Mammalian chemokines
AU4136797A (en) Novel semaphorin gene: semaphorin y
SE9704141D0 (sv) New protein and nucleotide sequence, encoding said protein
EP0892064A3 (en) Recombinant secA2 polypeptide from Staphylococcus aureus and uses thereof
CA2235471A1 (en) Dna encoding a plasminogen activating protein
WO2001002429A3 (en) Angiopoietin-6 and uses thereof
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
AU6839900A (en) Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence